Rubius Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
1.00
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.39
|
-0.36
|
0.03
|
7.69%
|
|
2022-06-30
|
-0.53
|
-0.49
|
0.04
|
7.55%
|
|
2022-03-31
|
-0.58
|
-0.58
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.59
|
-0.61
|
-0.02
|
-3.39%
|
|
2021-09-30
|
-0.57
|
-0.55
|
0.02
|
3.51%
|
|
2021-06-30
|
-0.49
|
-0.56
|
-0.07
|
-14.29%
|
|
2021-03-31
|
-0.52
|
-0.51
|
0.01
|
1.92%
|
|
2020-12-31
|
-0.49
|
-0.50
|
-0.01
|
-2.04%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.43
|
|
2021-12-31
|
-2.23
|
|
2020-12-31
|
-2.08
|
|
2019-12-31
|
-2.07
|
|
2018-12-31
|
-4.68
|